]>
IRCT2015070523067N1 IRCT 2015-08-13 Endocrine Research Center, Tabriz University of Medical Sciences The effect of fish-oil supplementation on lipid profile of pregnant mothers: a randomized controlled trial The effect of fish-oil supplementation on lipid profile of pregnant mothers: a randomized controlled trial 2014-11-27 anticipated 150 Complete https://irct.ir/trial/19772 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. 2-3 Lipid levels in Pegnant women. Intervention 1: Group interventions: fish oil capsules (containing 120 mg of DHA and 180 mg, 1000 mg EPA) ,Every day 1 number. Intervention 2: Control group: placebo (same shape, size and weight with other capsules ,Every day 1 number.
public Hossein Aslani
Imam Reza Hospital, Tabriz Department Of Internal Medicine
Tabriz Iran (Islamic Republic of) +98 41 3382 3655 hosseinaslani1990@gmail.com Tabriz University of Medical Sciences scientific Dr.Esamail Faraji
Tabriz University of Medical Sciences, Daneshgah Square, Imam Reza Hospital, Tabriz Department Of Internal Medicine
Tabriz Iran (Islamic Republic of) +98 41 3335 7850 farajie@tbzmed.ac.ir Tabriz University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: willingness to participate in the study, aged 18-35 years, first to fifth pregnancy, pregnant women with 16-20weeks of gestation, single pregnancy; BMI less than 30, healthy pregnant women with no previous underlying medical condition, including heart disease, kidney, gastrointestinal, respiratory, autoimmune, diabetes, impaired glucose tolerance testing in the current pregnancy, thyroid, epilepsy, hypertension underlying psychiatric disorders, hyperlipidemia and not to use any drugs because of the above conditions .Exclusion criteria:, bleeding, placenta previa, placenta detachment in current pregnancy, infertility and premature labor history, the existence of any history of allergy to fish or fish oil or other products or allergic to gelatin, the unfortunate incident that had occurred 6 months prior to the study, smoking or drugs, bleeding disorders or taking anticoagulants, participating in another study 18 years 35 years Female 094-095-09 Other obstetric conditions, not elsewhere classified Treatment - Drugs Placebo Group interventions: fish oil capsules (containing 120 mg of DHA and 180 mg, 1000 mg EPA) ,Every day 1 number Control group: placebo (same shape, size and weight with other capsules ,Every day 1 number Lipid Profile. Timepoint: begiining of study,fifth care of pregnancy. Method of measurement: blood analysis. Endocrine Research Center, Tabriz University of Medical Sciences Approved 2015-06-24 Ethics Committee of Tabriz University of Medical Sciences Tabriz University of Medical Sciences, Daneshgah Square Tabriz, Tabriz Tabriz Iran (Islamic Republic of)